|
|
| Product Name: | MM 07 | | Synonyms: | MM 07;CRPRLCHKGPMPF(Modification: Disulfide bridge: 1-6);MM 07 TFA | | CAS: | 1876450-21-3 | | MF: | C67H106N22O14S3 | | MW: | 1539.91 | | EINECS: | | | Product Categories: | | | Mol File: | 1876450-21-3.mol |  |
| | MM 07 Chemical Properties |
| density | 1.52±0.1 g/cm3(Predicted) | | storage temp. | Store at -20° C | | pka | 3.56±0.10(Predicted) | | form | Solid | | color | White to off-white | | Water Solubility | Souble in water | | Sequence | Cys-Arg-Pro-Arg-Leu-Cys-His-Lys-Gly-Pro-Met-Pro-Phe (Disulfide bridge:Cys1-Cys6) |
| | MM 07 Usage And Synthesis |
| Uses | MM 07 is a biased apelin receptor agonist, with a KD of 300 nM in CHO-K1 cells and a KD of 172 nM in human heart. | | in vivo | MM 07 causes a dose-dependent increase in cardiac output, and although there is a decrease in vascular resistance, this is without corresponding effects on BP. Administration of SNAP produces a profound fall in BP in both [Pyr1]apelin-13 and MM 07-treated groups; however, although cardiac output is significantly increased in response to SNAP in the MM 07 group, it is significantly reduced in the [Pyr1]apelin-13 group. Neither peptide causes a significant change in heart rate, respiratory rate, or temperature. Both [Pyr1]apelin 13 and MM 07 increases peak velocity above basal levels[1]. | | References | [1] Brame AL, et al. Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist. Hypertension. 2015 Apr;65(4):834-40. DOI:10.1161/HYPERTENSIONAHA.114.05099 |
| | MM 07 Preparation Products And Raw materials |
|